- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Health
Eliem Therapeutics engages with IPO process
Access Biotechnology is in line for an exit after the neuronal excitability disorder drug developer filed to float on the Nasdaq Global Market.
Jul 21, 2021Daily Deal Round Up: July 20, 2021
Telefónica-backed addiction treatment app developer Quit Genius raised $64m while oral care product maker NYSCPS received almost as much in a round featuring ByteDance.
Jul 20, 2021Corporates united in the US ecosystem
Innovative regions: California, New York, Massachusetts, Texas
Jul 20, 2021Electric grid girds itself for tense decades ahead
The global electricity market is worth around $3 trillion a year and is only likely to get bigger. But if electricity power generation fails to keep up with demand securely and flexibly, what trade-offs need to be made for which devices gets what level of allocation?
Jul 20, 2021Lozman becomes MD at M Ventures
The internal promotion at Merck Group's corporate venturing subsidiary followed the departure in May of Jasper Bos.
Jul 20, 2021TScan takes in $100m through IPO
Harvard spinout TScan Therapeutics has successfully listed on the Nasdaq Global Market.
Jul 19, 2021Ribon Therapeutics cribs $65m
Osage University Partners has returned to back the cancer and inflammatory drug developer based on research from multiple universities.
Jul 19, 2021Daily Deal Round Up: July 19, 2021
Debt repayment platform developer InDebted received $18.4m from investors including MassMutual, while corporate-backed AdaptiveMobile, Immersal and Pocket Casts are all being acquired.
Jul 19, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
